Trial Profile
A Study to Evaluate the Efficacy of Bortezomib-containing Regimens for the Treatment of Multiple Myeloma Patients with Extramedullary Plasmacytoma Invasion of the Spinal Canal.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 27 Nov 2015 New trial record